Spine BioPharma, Inc.
PrivateLast Round
Seed Round
Jun 5, 2026
Est. Valuation
$62.4M
Total Funding Raised
$17.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Spine BioPharma, Inc. is a biopharmaceutical company that develops non-surgical, non-opiate therapies for degenerative spine-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spine BioPharma, Inc. Comparables
Compare Spine BioPharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiscGenics | 85% | |
| Notogen Inc. | 80% | |
| Stayble Therapeutics AB | 79% |
Spine BioPharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 5, 2026 | ||||
| Early Funding | Dec 18, 2024 | ||||
| Series B | Mar 24, 2022 | ||||
| Convertible Debt | Apr 20, 2021 | ||||
| Series A | Apr 1, 2021 |
Key People
Founding team and executive leadership
Spine BioPharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cercano Management | Series A |
| VBW | Series A, Series B |
| Cercano Management | Series B |
| Viscogliosi Brothers, LLC | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
$385K raised in Seed Round.
- Apr 17, 2026
Monthly visitors increased 146% MoM, reaching 5.3K.
Spine BioPharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Spine BioPharma, Inc.'s valuation, stock price, and market status.
Is Spine BioPharma, Inc. a public or private company?
Spine BioPharma, Inc. is a private company.
What is the current stock price of Spine BioPharma, Inc.?
Spine BioPharma, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Spine BioPharma, Inc. worth (valuation)?
Valuation information for Spine BioPharma, Inc. is not publicly available.
Can I buy Spine BioPharma, Inc. stock?
Spine BioPharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Spine BioPharma, Inc.'s last funding round?
Spine BioPharma, Inc.'s most recent funding round was Seed Round on June 5, 2026.
Who are the main investors in Spine BioPharma, Inc.?
Investor information for Spine BioPharma, Inc. is not publicly disclosed.
Will Spine BioPharma, Inc. IPO soon?
No public IPO plans have been announced for Spine BioPharma, Inc..
How can I track Spine BioPharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spine BioPharma, Inc.'s secondary market activity and sign up for updates.